Methyl 6-hydroxybicyclo[2.2.2]octane-2-carboxylate

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: Methyl 6-hydroxybicyclo[2.2.2]octane-2-carboxylate
• 化学式: C₁₀H₁₆O₃
• mdl: MFCD24390342
• 分子量: 184.23
• InChiKey: HFIRAHKXIVJIBZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.9
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  3

文献信息

• Method of neutralising organoboronates with acids
  申请人：Russell Patric Vincent

  公开号：US20060172978A1

  公开（公告）日：2006-08-03

  The use of specified compounds for the manufacture of a medicament for therapeutically neutralising an organoboronate drug. The specified compounds are typically hydroxy fatty acids or hydroperoxy fatty acids, for example 9(S)-HODE, 8(S)-HETRE or 8(S)-HEPE, or their salts or prodrugs. The organoboronate drug may be TRI 50c or a salt or prodrug thereof. Also disclosed are intravenous formulations containing the specified compounds.
• METHOD OF NEUTRALISING ORGANOBORONATES WITH ACIDS
  申请人：Russel Vincent Patric

  公开号：US20100022646A1

  公开（公告）日：2010-01-28

  The use of specified compounds for the manufacture of a medicament for therapeutically neutralising an organoboronate drug. The specified compounds are typically hydroxy fatty acids or hydroperoxy fatty acids, for example 9(S)-HODE, 8(S)-HETRE or 8(S)-HEPE, or their salts or prodrugs. The organoboronate drug may be TRI 50c or a salt or prodrug thereof. Also disclosed are intravenous formulations containing the specified compounds.